{"metadata":{"kernelspec":{"language":"python","display_name":"Python 3","name":"python3"},"language_info":{"name":"python","version":"3.11.13","mimetype":"text/x-python","codemirror_mode":{"name":"ipython","version":3},"pygments_lexer":"ipython3","nbconvert_exporter":"python","file_extension":".py"},"kaggle":{"accelerator":"none","dataSources":[],"dockerImageVersionId":31192,"isInternetEnabled":true,"language":"python","sourceType":"notebook","isGpuEnabled":false}},"nbformat_minor":4,"nbformat":4,"cells":[{"cell_type":"code","source":"# This Python 3 environment comes with many helpful analytics libraries installed\n# It is defined by the kaggle/python Docker image: https://github.com/kaggle/docker-python\n# For example, here's several helpful packages to load\n\nimport numpy as np # linear algebra\nimport pandas as pd # data processing, CSV file I/O (e.g. pd.read_csv)\n\n# Input data files are available in the read-only \"../input/\" directory\n# For example, running this (by clicking run or pressing Shift+Enter) will list all files under the input directory\n\nimport os\nfor dirname, _, filenames in os.walk('/kaggle/input'):\n    for filename in filenames:\n        print(os.path.join(dirname, filename))\n\n# You can write up to 20GB to the current directory (/kaggle/working/) that gets preserved as output when you create a version using \"Save & Run All\" \n# You can also write temporary files to /kaggle/temp/, but they won't be saved outside of the current session","metadata":{"_uuid":"8f2839f25d086af736a60e9eeb907d3b93b6e0e5","_cell_guid":"b1076dfc-b9ad-4769-8c92-a6c4dae69d19","trusted":true,"execution":{"iopub.status.busy":"2025-11-12T04:34:42.755397Z","iopub.execute_input":"2025-11-12T04:34:42.755654Z","iopub.status.idle":"2025-11-12T04:34:45.108358Z","shell.execute_reply.started":"2025-11-12T04:34:42.755632Z","shell.execute_reply":"2025-11-12T04:34:45.106438Z"}},"outputs":[],"execution_count":1},{"cell_type":"code","source":"from kaggle_secrets import UserSecretsClient\nuser_secrets = UserSecretsClient()\nsecret_value_0 = user_secrets.get_secret(\"GOOGLE_API_KEY\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T04:34:56.055803Z","iopub.execute_input":"2025-11-12T04:34:56.056122Z","iopub.status.idle":"2025-11-12T04:34:56.200156Z","shell.execute_reply.started":"2025-11-12T04:34:56.056099Z","shell.execute_reply":"2025-11-12T04:34:56.199112Z"}},"outputs":[],"execution_count":2},{"cell_type":"code","source":"import os\nfrom kaggle_secrets import UserSecretsClient\n\ntry:\n    GOOGLE_API_KEY = UserSecretsClient().get_secret(\"GOOGLE_API_KEY\")\n    os.environ[\"GOOGLE_API_KEY\"] = GOOGLE_API_KEY\n    print(\"âœ… Gemini API key setup complete.\")\nexcept Exception as e:\n    print(\n        f\"ðŸ”‘ Authentication Error: Please make sure you have added 'GOOGLE_API_KEY' to your Kaggle secrets. Details: {e}\"\n    )","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T04:35:02.775634Z","iopub.execute_input":"2025-11-12T04:35:02.775942Z","iopub.status.idle":"2025-11-12T04:35:02.883657Z","shell.execute_reply.started":"2025-11-12T04:35:02.775916Z","shell.execute_reply":"2025-11-12T04:35:02.882524Z"}},"outputs":[{"name":"stdout","text":"âœ… Gemini API key setup complete.\n","output_type":"stream"}],"execution_count":3},{"cell_type":"code","source":"from typing import Any, Dict\n\nfrom google.adk.agents import Agent, LlmAgent\nfrom google.adk.apps.app import App, EventsCompactionConfig\nfrom google.adk.models.google_llm import Gemini\nfrom google.adk.sessions import DatabaseSessionService\nfrom google.adk.sessions import InMemorySessionService\nfrom google.adk.runners import Runner\nfrom google.adk.tools.tool_context import ToolContext\nfrom google.genai import types\n\nprint(\"âœ… ADK components imported successfully.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T04:35:07.753217Z","iopub.execute_input":"2025-11-12T04:35:07.753552Z","iopub.status.idle":"2025-11-12T04:36:00.146512Z","shell.execute_reply.started":"2025-11-12T04:35:07.753526Z","shell.execute_reply":"2025-11-12T04:36:00.145297Z"}},"outputs":[{"name":"stdout","text":"âœ… ADK components imported successfully.\n","output_type":"stream"}],"execution_count":4},{"cell_type":"code","source":"# Define helper functions that will be reused throughout the notebook\nasync def run_session(\n    runner_instance: Runner,\n    user_queries: list[str] | str = None,\n    session_name: str = \"default\",\n):\n    print(f\"\\n ### Session: {session_name}\")\n\n    # Get app name from the Runner\n    app_name = runner_instance.app_name\n\n    # Attempt to create a new session or retrieve an existing one\n    try:\n        session = await session_service.create_session(\n            app_name=app_name, user_id=USER_ID, session_id=session_name\n        )\n    except:\n        session = await session_service.get_session(\n            app_name=app_name, user_id=USER_ID, session_id=session_name\n        )\n\n    # Process queries if provided\n    if user_queries:\n        # Convert single query to list for uniform processing\n        if type(user_queries) == str:\n            user_queries = [user_queries]\n\n        # Process each query in the list sequentially\n        for query in user_queries:\n            print(f\"\\nUser > {query}\")\n\n            # Convert the query string to the ADK Content format\n            query = types.Content(role=\"user\", parts=[types.Part(text=query)])\n\n            # Stream the agent's response asynchronously\n            async for event in runner_instance.run_async(\n                user_id=USER_ID, session_id=session.id, new_message=query\n            ):\n                # Check if the event contains valid content\n                if event.content and event.content.parts:\n                    # Filter out empty or \"None\" responses before printing\n                    if (\n                        event.content.parts[0].text != \"None\"\n                        and event.content.parts[0].text\n                    ):\n                        print(f\"{MODEL_NAME} > \", event.content.parts[0].text)\n    else:\n        print(\"No queries!\")\n\n\nprint(\"âœ… Helper functions defined.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T04:36:57.160358Z","iopub.execute_input":"2025-11-12T04:36:57.160691Z","iopub.status.idle":"2025-11-12T04:36:57.169431Z","shell.execute_reply.started":"2025-11-12T04:36:57.160667Z","shell.execute_reply":"2025-11-12T04:36:57.168371Z"}},"outputs":[{"name":"stdout","text":"âœ… Helper functions defined.\n","output_type":"stream"}],"execution_count":7},{"cell_type":"code","source":"retry_config = types.HttpRetryOptions(\n    attempts=5,  # Maximum retry attempts\n    exp_base=7,  # Delay multiplier\n    initial_delay=1,\n    http_status_codes=[429, 500, 503, 504],  # Retry on these HTTP errors\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T04:37:02.692354Z","iopub.execute_input":"2025-11-12T04:37:02.692668Z","iopub.status.idle":"2025-11-12T04:37:02.698250Z","shell.execute_reply.started":"2025-11-12T04:37:02.692642Z","shell.execute_reply":"2025-11-12T04:37:02.697085Z"}},"outputs":[],"execution_count":8},{"cell_type":"code","source":"APP_NAME = \"default\"  # Application\nUSER_ID = \"default\"  # User\nSESSION = \"default\"  # Session\n\nMODEL_NAME = \"gemini-2.5-flash-lite\"\n\n\n# Step 1: Create the LLM Agent\nroot_agent = Agent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"A text chatbot\",  # Description of the agent's purpose\n)\n\n# Step 2: Set up Session Management\n# InMemorySessionService stores conversations in RAM (temporary)\nsession_service = InMemorySessionService()\n\n# Step 3: Create the Runner\nrunner = Runner(agent=root_agent, app_name=APP_NAME, session_service=session_service)\n\nprint(\"âœ… Stateful agent initialized!\")\nprint(f\"   - Application: {APP_NAME}\")\nprint(f\"   - User: {USER_ID}\")\nprint(f\"   - Using: {session_service.__class__.__name__}\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T04:37:06.163738Z","iopub.execute_input":"2025-11-12T04:37:06.164079Z","iopub.status.idle":"2025-11-12T04:37:06.172907Z","shell.execute_reply.started":"2025-11-12T04:37:06.164056Z","shell.execute_reply":"2025-11-12T04:37:06.171885Z"}},"outputs":[{"name":"stdout","text":"âœ… Stateful agent initialized!\n   - Application: default\n   - User: default\n   - Using: InMemorySessionService\n","output_type":"stream"}],"execution_count":9},{"cell_type":"code","source":"# Run a conversation with two queries in the same session\n# Notice: Both queries are part of the SAME session, so context is maintained\nawait run_session(\n    runner,\n    [\n        \"Hi, I am Sam! What is the capital of United States?\",\n        \"Hello! What is my name?\",  # This time, the agent should remember!\n    ],\n    \"stateful-agentic-session\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T04:38:42.149430Z","iopub.execute_input":"2025-11-12T04:38:42.149758Z","iopub.status.idle":"2025-11-12T04:38:43.292359Z","shell.execute_reply.started":"2025-11-12T04:38:42.149735Z","shell.execute_reply":"2025-11-12T04:38:43.291135Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: stateful-agentic-session\n\nUser > Hi, I am Sam! What is the capital of United States?\ngemini-2.5-flash-lite >  Hi Sam! The capital of the United States is Washington, D.C.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  You told me your name is Sam.\n","output_type":"stream"}],"execution_count":12},{"cell_type":"code","source":"# Run this cell after restarting the kernel. All this history will be gone...\nawait run_session(\n    runner,\n    [\"What did I ask you about earlier?\", \"And remind me, what's my name?\"],\n    \"stateful-agentic-session\",\n)  # Note, we are using same session name","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T04:38:47.355729Z","iopub.execute_input":"2025-11-12T04:38:47.356116Z","iopub.status.idle":"2025-11-12T04:38:48.278715Z","shell.execute_reply.started":"2025-11-12T04:38:47.356089Z","shell.execute_reply":"2025-11-12T04:38:48.277874Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: stateful-agentic-session\n\nUser > What did I ask you about earlier?\ngemini-2.5-flash-lite >  You asked me about the capital of the United States.\n\nUser > And remind me, what's my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":13},{"cell_type":"code","source":"# Step 1: Create the same agent (notice we use LlmAgent this time)\nchatbot_agent = LlmAgent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"A text chatbot with persistent memory\",\n)\n\n# Step 2: Switch to DatabaseSessionService\n# SQLite database will be created automatically\ndb_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\nsession_service = DatabaseSessionService(db_url=db_url)\n\n# Step 3: Create a new runner with persistent storage\nrunner = Runner(agent=chatbot_agent, app_name=APP_NAME, session_service=session_service)\n\nprint(\"âœ… Upgraded to persistent sessions!\")\nprint(f\"   - Database: my_agent_data.db\")\nprint(f\"   - Sessions will survive restarts!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T04:38:51.644166Z","iopub.execute_input":"2025-11-12T04:38:51.644470Z","iopub.status.idle":"2025-11-12T04:38:51.655503Z","shell.execute_reply.started":"2025-11-12T04:38:51.644450Z","shell.execute_reply":"2025-11-12T04:38:51.654160Z"}},"outputs":[{"name":"stdout","text":"âœ… Upgraded to persistent sessions!\n   - Database: my_agent_data.db\n   - Sessions will survive restarts!\n","output_type":"stream"}],"execution_count":14},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\"Hi, I am Sam! What is the capital of the United States?\", \"Hello! What is my name?\"],\n    \"test-db-session-01\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T04:30:58.309813Z","iopub.execute_input":"2025-11-12T04:30:58.310615Z","iopub.status.idle":"2025-11-12T04:30:59.329339Z","shell.execute_reply.started":"2025-11-12T04:30:58.310585Z","shell.execute_reply":"2025-11-12T04:30:59.328456Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-01\n\nUser > Hi, I am Sam! What is the capital of the United States?\ngemini-2.5-flash-lite >  Hi Sam! The capital of the United States is Washington, D.C.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  Your name is Sam.\n","output_type":"stream"}],"execution_count":13},{"cell_type":"code","source":"await run_session(\n    runner,\n    [\"What is the capital of India?\", \"Hello! What is my name?\"],\n    \"test-db-session-01\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T04:38:58.070752Z","iopub.execute_input":"2025-11-12T04:38:58.071358Z","iopub.status.idle":"2025-11-12T04:38:59.434849Z","shell.execute_reply.started":"2025-11-12T04:38:58.071322Z","shell.execute_reply":"2025-11-12T04:38:59.433958Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-01\n\nUser > What is the capital of India?\ngemini-2.5-flash-lite >  The capital of India is New Delhi.\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  I do not have access to your personal information, including your name. I am a text-based AI and do not store user data for privacy reasons.\n","output_type":"stream"}],"execution_count":15},{"cell_type":"code","source":"await run_session(\n    runner, [\"Hello! What is my name?\"], \"test-db-session-02\"\n)  # Note, we are using new session name","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T04:39:31.239399Z","iopub.execute_input":"2025-11-12T04:39:31.239731Z","iopub.status.idle":"2025-11-12T04:39:31.849918Z","shell.execute_reply.started":"2025-11-12T04:39:31.239706Z","shell.execute_reply":"2025-11-12T04:39:31.848990Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: test-db-session-02\n\nUser > Hello! What is my name?\ngemini-2.5-flash-lite >  I do not have access to your personal information, including your name. Therefore, I cannot tell you what your name is.\n","output_type":"stream"}],"execution_count":16},{"cell_type":"code","source":"import sqlite3\n\ndef check_data_in_db():\n    with sqlite3.connect(\"my_agent_data.db\") as connection:\n        cursor = connection.cursor()\n        result = cursor.execute(\n            \"select app_name, session_id, author, content from events\"\n        )\n        print([_[0] for _ in result.description])\n        for each in result.fetchall():\n            print(each)\n\n\ncheck_data_in_db()","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T04:40:04.855380Z","iopub.execute_input":"2025-11-12T04:40:04.855715Z","iopub.status.idle":"2025-11-12T04:40:04.864139Z","shell.execute_reply.started":"2025-11-12T04:40:04.855693Z","shell.execute_reply":"2025-11-12T04:40:04.862883Z"}},"outputs":[{"name":"stdout","text":"['app_name', 'session_id', 'author', 'content']\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"What is the capital of India?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"The capital of India is New Delhi.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"I do not have access to your personal information, including your name. I am a text-based AI and do not store user data for privacy reasons.\"}], \"role\": \"model\"}')\n('default', 'stateful-agentic-session', 'user', '{\"parts\": [{\"text\": \"Hi, I am Sam! What is the capital of United States?\"}], \"role\": \"user\"}')\n('default', 'stateful-agentic-session', 'text_chat_bot', '{\"parts\": [{\"text\": \"Hi Sam! The capital of the United States is Washington, D.C.\"}], \"role\": \"model\"}')\n('default', 'stateful-agentic-session', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'stateful-agentic-session', 'text_chat_bot', '{\"parts\": [{\"text\": \"You told me your name is Sam.\"}], \"role\": \"model\"}')\n('default', 'stateful-agentic-session', 'user', '{\"parts\": [{\"text\": \"What did I ask you about earlier?\"}], \"role\": \"user\"}')\n('default', 'stateful-agentic-session', 'text_chat_bot', '{\"parts\": [{\"text\": \"You asked me about the capital of the United States.\"}], \"role\": \"model\"}')\n('default', 'stateful-agentic-session', 'user', '{\"parts\": [{\"text\": \"And remind me, what\\'s my name?\"}], \"role\": \"user\"}')\n('default', 'stateful-agentic-session', 'text_chat_bot', '{\"parts\": [{\"text\": \"Your name is Sam.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"What is the capital of India?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"The capital of India is New Delhi.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-01', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-01', 'text_chat_bot', '{\"parts\": [{\"text\": \"I do not have access to your personal information, including your name. I am a text-based AI and do not store user data for privacy reasons.\"}], \"role\": \"model\"}')\n('default', 'test-db-session-02', 'user', '{\"parts\": [{\"text\": \"Hello! What is my name?\"}], \"role\": \"user\"}')\n('default', 'test-db-session-02', 'text_chat_bot', '{\"parts\": [{\"text\": \"I do not have access to your personal information, including your name. Therefore, I cannot tell you what your name is.\"}], \"role\": \"model\"}')\n","output_type":"stream"}],"execution_count":17},{"cell_type":"code","source":"# Re-define our app with Events Compaction enabled\nresearch_app_compacting = App(\n    name=\"research_app_compacting\",\n    root_agent=chatbot_agent,\n    # This is the new part!\n    events_compaction_config=EventsCompactionConfig(\n        compaction_interval=3,  # Trigger compaction every 3 invocations\n        overlap_size=1,  # Keep 1 previous turn for context\n    ),\n)\n\ndb_url = \"sqlite:///my_agent_data.db\"  # Local SQLite file\nsession_service = DatabaseSessionService(db_url=db_url)\n\n# Create a new runner for our upgraded app\nresearch_runner_compacting = Runner(\n    app=research_app_compacting, session_service=session_service\n)\n\n\nprint(\"âœ… Research App upgraded with Events Compaction!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T04:43:39.637415Z","iopub.execute_input":"2025-11-12T04:43:39.637789Z","iopub.status.idle":"2025-11-12T04:43:39.648341Z","shell.execute_reply.started":"2025-11-12T04:43:39.637764Z","shell.execute_reply":"2025-11-12T04:43:39.646993Z"}},"outputs":[{"name":"stdout","text":"âœ… Research App upgraded with Events Compaction!\n","output_type":"stream"},{"name":"stderr","text":"/tmp/ipykernel_49/3773147741.py:6: UserWarning: [EXPERIMENTAL] EventsCompactionConfig: This feature is experimental and may change or be removed in future versions without notice. It may introduce breaking changes at any time.\n  events_compaction_config=EventsCompactionConfig(\n","output_type":"stream"}],"execution_count":18},{"cell_type":"code","source":"# Turn 1\nawait run_session(\n    research_runner_compacting,\n    \"What is the latest news about AI in healthcare?\",\n    \"compaction_demo\",\n)\n\n# Turn 2\nawait run_session(\n    research_runner_compacting,\n    \"Are there any new developments in drug discovery?\",\n    \"compaction_demo\",\n)\n\n# Turn 3 - Compaction should trigger after this turn!\nawait run_session(\n    research_runner_compacting,\n    \"Tell me more about the second development you found.\",\n    \"compaction_demo\",\n)\n\n# Turn 4\nawait run_session(\n    research_runner_compacting,\n    \"Who are the main companies involved in that?\",\n    \"compaction_demo\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T04:44:25.771203Z","iopub.execute_input":"2025-11-12T04:44:25.771570Z","iopub.status.idle":"2025-11-12T04:44:42.069141Z","shell.execute_reply.started":"2025-11-12T04:44:25.771545Z","shell.execute_reply":"2025-11-12T04:44:42.068120Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: compaction_demo\n\nUser > What is the latest news about AI in healthcare?\ngemini-2.5-flash-lite >  Here's a summary of the latest news and trends in AI in healthcare, covering key areas:\n\n**1. Drug Discovery and Development:**\n\n*   **Accelerated Drug Discovery:** AI continues to revolutionize drug discovery by identifying potential drug candidates much faster than traditional methods. Companies are using AI to analyze vast datasets of biological and chemical information, predict molecular interactions, and design novel compounds.\n*   **Personalized Medicine:** AI is crucial for developing personalized treatments. By analyzing a patient's genetic makeup, medical history, and lifestyle data, AI can help predict their response to different drugs and tailor treatment plans for better efficacy and fewer side effects.\n*   **Clinical Trial Optimization:** AI is being used to improve the efficiency of clinical trials by identifying suitable patient populations, predicting trial outcomes, and monitoring patient progress. This can lead to faster drug approvals and reduced costs.\n\n**2. Diagnostics and Imaging:**\n\n*   **AI-Powered Medical Imaging Analysis:** AI algorithms are becoming increasingly sophisticated at analyzing medical images like X-rays, CT scans, and MRIs. They can detect subtle anomalies that might be missed by human eyes, aiding in the early diagnosis of diseases like cancer, diabetic retinopathy, and cardiovascular conditions.\n*   **Pathology Advancements:** AI is transforming digital pathology by automating the analysis of tissue samples. This can help pathologists identify cancerous cells more accurately and efficiently, leading to quicker diagnoses and treatment.\n*   **Radiology Assistance:** AI tools are acting as a \"second pair of eyes\" for radiologists, flagging potential abnormalities and prioritizing urgent cases, thereby improving workflow and reducing burnout.\n\n**3. Predictive Analytics and Early Disease Detection:**\n\n*   **Forecasting Disease Outbreaks:** AI is being used to predict and track the spread of infectious diseases by analyzing public health data, social media trends, and news reports.\n*   **Early Warning Systems:** AI can identify patients at high risk for developing certain conditions (e.g., sepsis, heart failure, hospital readmissions) by continuously monitoring electronic health records (EHRs) and other patient data. This allows for proactive interventions.\n*   **Personalized Risk Assessment:** Beyond general risk, AI is enabling more precise individual risk assessments for various diseases based on a multitude of factors.\n\n**4. Workflow Automation and Administrative Tasks:**\n\n*   **Reducing Administrative Burden:** AI-powered tools are automating routine administrative tasks like appointment scheduling, medical coding, and claims processing, freeing up healthcare professionals to focus on patient care.\n*   **Improving EHR Efficiency:** AI is being integrated into EHR systems to streamline data entry, provide real-time clinical decision support, and improve the overall usability of these systems.\n*   **Virtual Assistants and Chatbots:** AI-powered chatbots are being used for patient triage, answering common medical questions, and providing appointment reminders, improving patient engagement and accessibility.\n\n**5. Robotic Surgery and Medical Devices:**\n\n*   **Enhanced Surgical Precision:** AI is augmenting robotic surgery systems, providing surgeons with more precise control, real-time guidance, and improved visualization during complex procedures.\n*   **Smart Medical Devices:** AI is being embedded in wearable devices and implantable sensors to continuously monitor patient health, detect abnormalities, and provide personalized health insights.\n\n**Key Trends and Considerations:**\n\n*   **Explainable AI (XAI):** There's a growing demand for AI systems that can explain their reasoning and decision-making processes. This is crucial for building trust among clinicians and patients and for regulatory approval.\n*   **Data Privacy and Security:** As AI in healthcare relies heavily on sensitive patient data, robust data privacy and security measures are paramount. Regulations like HIPAA are being adapted to address AI's use.\n*   **Regulatory Landscape:** Regulatory bodies like the FDA are actively developing frameworks for the approval and oversight of AI-powered medical devices and software.\n*   **Ethical Implications:** Discussions around bias in AI algorithms, equitable access to AI-driven healthcare, and the potential impact on the healthcare workforce are ongoing.\n*   **Interoperability:** A significant challenge remains in ensuring that AI systems can seamlessly integrate with existing healthcare IT infrastructure and data sources.\n\n**In summary, AI in healthcare is rapidly moving from research and development into practical applications. Its potential to improve diagnosis, personalize treatment, accelerate drug discovery, and optimize healthcare operations is immense, but careful consideration of ethical, regulatory, and implementation challenges is essential for its successful and equitable adoption.**\n\nTo get the absolute latest breaking news, I would recommend checking reputable sources like:\n\n*   **PubMed/Medical Journals:** For peer-reviewed research.\n*   **Industry News Outlets:** Such as Fierce Biotech, STAT News, MobiHealthNews, Healthcare IT News.\n*   **Major Tech Company Blogs:** Companies like Google Health, Microsoft Healthcare, IBM Watson Health often share their latest advancements.\n*   **Conferences and Events:** Proceedings and announcements from major healthcare and AI conferences.\n\n ### Session: compaction_demo\n\nUser > Are there any new developments in drug discovery?\ngemini-2.5-flash-lite >  Yes, there are continuous and exciting new developments in AI-driven drug discovery! Here are some of the key areas and recent trends:\n\n**1. Generative AI for Novel Molecule Design:**\n\n*   **De Novo Design:** This is a major area of advancement. Generative AI models (like GANs, VAEs, and diffusion models) are now being used to *design entirely new molecules* with desired properties, rather than just screening existing libraries. They can learn the \"rules\" of chemistry and generate structures that are not found in nature but are predicted to be effective and safe.\n*   **Targeted Design:** These generative models can be guided to design molecules that specifically bind to a particular protein target, address a specific disease pathway, or have desired pharmacokinetic properties (how the body absorbs, distributes, metabolizes, and excretes the drug).\n*   **\"Dreaming Up\" New Therapies:** Researchers are using these tools to explore vast chemical spaces, essentially \"dreaming up\" novel therapeutic candidates that human intuition might not conceive.\n\n**2. AI for Predicting Drug Properties and Efficacy:**\n\n*   **Quantitative Structure-Activity Relationship (QSAR) Models:** AI is significantly enhancing QSAR models, which predict the biological activity of a molecule based on its chemical structure. Deep learning models can capture more complex relationships than traditional methods.\n*   **Predicting ADMET Properties:** AI is becoming much better at predicting Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) properties early in the discovery process. This helps to de-risk candidates and reduce late-stage failures, which are notoriously expensive.\n*   **Virtual Screening on Steroids:** AI can screen billions of potential compounds virtually far more efficiently than traditional methods, identifying promising candidates for further experimental testing.\n\n**3. AI in Target Identification and Validation:**\n\n*   **Uncovering New Targets:** AI algorithms analyze vast biological datasets (genomics, proteomics, transcriptomics, clinical data) to identify novel disease-associated genes and proteins that could serve as new drug targets.\n*   **Understanding Disease Mechanisms:** AI helps researchers piece together complex biological pathways and interactions, leading to a deeper understanding of disease mechanisms and the identification of key intervention points.\n*   **Prioritizing Targets:** AI can help prioritize which potential drug targets are most likely to yield successful therapies based on a multitude of factors.\n\n**4. AI for Optimizing Clinical Trials:**\n\n*   **Patient Stratification:** AI can identify patient subgroups who are most likely to respond to a specific drug, leading to more efficient and successful clinical trials.\n*   **Predicting Trial Outcomes:** AI models are being developed to predict the likelihood of success for a clinical trial based on preclinical data, trial design, and historical trial performance.\n*   **Biomarker Discovery:** AI can identify biomarkers that predict drug response or disease progression, which are crucial for personalized medicine and trial design.\n\n**5. AI in Repurposing Existing Drugs:**\n\n*   **Finding New Uses for Old Drugs:** AI can analyze existing drug databases and disease information to identify drugs that might be effective for new indications, significantly shortening the development timeline and reducing costs.\n\n**Examples of Recent Progress & Notable Companies:**\n\nMany companies are at the forefront of this revolution. Some of the prominent ones include:\n\n*   **Recursion Pharmaceuticals:** Uses AI and automation to map human cellular biology and discover new drugs.\n*   **Exscientia:** Employs AI to design novel drug molecules and accelerate drug discovery.\n*   **Insilico Medicine:** Focuses on generative AI for drug discovery, with several candidates advancing through clinical trials.\n*   **Atomwise:** Uses deep learning for small molecule drug discovery.\n*   **BenevolentAI:** Leverages AI to analyze scientific literature and data to identify new drug targets and treatments.\n\n**Challenges and Future Outlook:**\n\nWhile the progress is remarkable, challenges remain:\n\n*   **Data Quality and Availability:** High-quality, curated data is crucial for training effective AI models.\n*   **Experimental Validation:** AI predictions still need rigorous experimental validation in the lab and clinic.\n*   **Interpretability:** Understanding *why* an AI model makes a certain prediction is important for trust and further refinement.\n*   **Regulatory Hurdles:** Ensuring AI-driven discoveries meet stringent regulatory standards.\n\nDespite these challenges, the integration of AI into drug discovery is transforming the pharmaceutical industry, promising faster, cheaper, and more effective development of new medicines. The trend is strongly towards more sophisticated generative AI and deeper integration of AI across the entire drug discovery pipeline.\n\n ### Session: compaction_demo\n\nUser > Tell me more about the second development you found.\ngemini-2.5-flash-lite >  You're asking about the second development I mentioned in my previous response about AI in drug discovery: **AI for Predicting Drug Properties and Efficacy.**\n\nThis area is absolutely critical because the vast majority of drug candidates fail during development, and a significant portion of these failures happen late in the process due to unforeseen toxicity or lack of efficacy. AI is a game-changer here because it can provide insights *much earlier* than traditional methods.\n\nLet's break down the key aspects of this development:\n\n**1. Predicting ADMET Properties (Absorption, Distribution, Metabolism, Excretion, and Toxicity):**\n\n*   **What it means:** This refers to how a drug behaves once it's in the body.\n    *   **Absorption:** How well does the drug get into the bloodstream?\n    *   **Distribution:** Where does the drug go in the body? Does it reach the target organ?\n    *   **Metabolism:** How does the body break down the drug? Are the byproducts harmful?\n    *   **Excretion:** How does the body get rid of the drug and its byproducts?\n    *   **Toxicity:** Is the drug safe? Does it cause harmful side effects at therapeutic doses?\n*   **How AI helps:**\n    *   **Machine Learning Models:** AI, particularly deep learning, can be trained on massive datasets of known drug molecules and their experimentally determined ADMET properties.\n    *   **Predictive Power:** These models can then predict the ADMET profile of *new, hypothetical molecules* before they are even synthesized in the lab.\n    *   **Early De-risking:** If a candidate molecule is predicted to have poor absorption or significant toxicity, researchers can discard it early, saving immense time and resources. Conversely, molecules predicted to have good ADMET profiles can be prioritized.\n    *   **Reducing Animal Testing:** By accurately predicting toxicity, AI can help reduce the need for extensive animal testing, which is both ethically sensitive and time-consuming.\n\n**2. Enhancing Quantitative Structure-Activity Relationship (QSAR) Models:**\n\n*   **What it means:** QSAR is a principle that the biological activity of a molecule is related to its chemical structure. QSAR models try to quantify this relationship.\n*   **How AI helps:**\n    *   **More Complex Relationships:** Traditional QSAR models often rely on predefined molecular descriptors. AI, especially deep learning, can learn much more complex and nuanced relationships between molecular structure and biological activity directly from data, without requiring predefined features.\n    *   **Higher Accuracy:** This leads to more accurate predictions of how potent a drug will be against its intended target.\n    *   **Predicting Efficacy:** By better understanding the structure-activity relationship, AI can help predict not just binding affinity, but also the likelihood of the drug producing the desired therapeutic effect in a biological system.\n\n**3. Advanced Virtual Screening:**\n\n*   **What it means:** Virtual screening involves computationally testing a large library of chemical compounds to see which ones are most likely to bind to a specific biological target (like a protein involved in a disease).\n*   **How AI helps:**\n    *   **Scalability and Speed:** AI algorithms can sift through billions of virtual compounds orders of magnitude faster than traditional methods.\n    *   **Sophisticated Docking:** AI can improve the accuracy of \"docking\" simulations, which predict how well a small molecule (drug candidate) fits into the binding site of a target protein.\n    *   **Beyond Simple Shape Matching:** AI can consider more complex factors like electrostatic interactions, solvation effects, and conformational flexibility, leading to more realistic predictions of binding.\n    *   **Hit Identification:** This process efficiently identifies \"hits\" â€“ compounds that show promising interaction with the target â€“ which can then be further optimized.\n\n**Why is this so important?**\n\nThink of it like building a skyscraper. You wouldn't start pouring concrete for the entire structure before you've thoroughly tested the foundation, the structural integrity of the beams, and the safety of the materials.\n\n*   **Traditional Approach:** Would involve synthesizing many compounds, testing them in labs, and then discovering issues with toxicity or poor absorption late in the pipeline, leading to costly failures.\n*   **AI-Assisted Approach:** Uses AI as a sophisticated \"digital engineer\" to pre-screen and pre-validate molecules. It helps identify the most promising candidates with the best chance of success *before* significant resources are invested in synthesis and extensive lab testing.\n\nThis development is about making the drug discovery process more efficient, less costly, and more likely to succeed by applying predictive intelligence at critical early stages.\n\n ### Session: compaction_demo\n\nUser > Who are the main companies involved in that?\ngemini-2.5-flash-lite >  You're asking about the companies leading the charge in using AI to predict drug properties and efficacy. This is a broad area, and many types of companies are involved, from large pharmaceutical giants to specialized AI-first biotech firms.\n\nHere's a breakdown of the types of companies and some notable examples:\n\n**1. AI-First Biotech Companies (often called \"AI Drug Discovery Companies\"):**\n\nThese companies were founded with AI at their core, building proprietary platforms and applying them to discover new drugs. They often focus on specific aspects of the AI pipeline, including property prediction.\n\n*   **Recursion Pharmaceuticals:** While they use AI across their platform for target identification and understanding disease biology, their ability to generate and analyze vast amounts of experimental data allows them to train sophisticated models that predict how compounds will behave in cellular systems, which is a proxy for efficacy and certain toxicity aspects.\n*   **Exscientia:** Known for their end-to-end AI platform that designs novel molecules and guides their progression. Their platform includes modules for predicting properties and optimizing candidates for better efficacy and ADMET.\n*   **Insilico Medicine:** A prominent player in generative AI for drug discovery, they also heavily rely on AI for predicting molecular properties, pharmacokinetic profiles, and potential toxicities. They have advanced several candidates into clinical trials based on their AI-driven approach.\n*   **Atomwise:** Focuses on using deep learning for small molecule drug discovery, which inherently involves predicting how well molecules will bind to targets and their potential properties.\n*   **Valo Health:** Aims to transform drug discovery by integrating AI and experimental biology. Their platform is designed to predict drug efficacy and safety profiles early on.\n*   **BenevolentAI:** Uses AI to mine scientific literature and data to identify targets and design molecules, with a strong emphasis on understanding disease mechanisms and predicting drug responses.\n*   **Schrodinger:** While they have a long history in computational chemistry, they've significantly integrated AI into their platform to enhance molecular modeling, property prediction, and virtual screening for drug discovery.\n\n**2. Large Pharmaceutical Companies (with significant AI investments):**\n\nMajor pharma companies recognize the transformative potential of AI and are heavily investing in internal AI capabilities and external partnerships. They often use AI for property prediction to accelerate their existing R&D pipelines.\n\n*   **Pfizer:** Has been investing heavily in AI and machine learning for drug discovery, including using it for target identification, lead optimization, and predicting clinical trial success.\n*   **Novartis:** Actively uses AI for various stages of drug discovery, including predicting molecular properties and optimizing candidate selection. They have dedicated AI research teams and collaborations.\n*   **Merck (MSD):** Is employing AI and machine learning to analyze large datasets, predict drug efficacy, and identify potential safety concerns earlier in the development cycle.\n*   **AstraZeneca:** Has established significant AI initiatives, often focusing on areas like early-stage discovery, computational chemistry, and predicting clinical outcomes.\n*   **Johnson & Johnson:** Invests in AI across its pharmaceutical segment, leveraging it to accelerate discovery, optimize molecule design, and predict drug performance.\n*   **Roche/Genentech:** Has been a leader in computational biology and is increasingly incorporating AI/ML into its discovery and development processes, including property prediction.\n\n**3. Specialized AI/ML Platform Providers:**\n\nSome companies focus specifically on developing the AI/ML tools and platforms that other companies (biotech and pharma) can license or use through partnerships.\n\n*   **NVIDIA:** While not a drug discovery company itself, NVIDIA's powerful GPUs and AI platforms are fundamental to the computational power required for training complex AI models used in drug discovery, including property prediction. They also offer specific healthcare AI platforms.\n*   **Various cloud providers (Amazon AWS, Google Cloud, Microsoft Azure):** These companies provide the infrastructure and AI/ML services that enable many drug discovery companies to build and deploy their AI models.\n\n**Key aspects they focus on in this domain:**\n\n*   **Predictive Toxicology:** Identifying potential off-target effects or inherent toxicities of drug candidates.\n*   **Pharmacokinetic (PK) and Pharmacodynamic (PD) Modeling:** Predicting how a drug is absorbed, distributed, metabolized, and excreted, and its effect on the body over time.\n*   **Solubility and Bioavailability Prediction:** Estimating how well a drug will dissolve and be absorbed into the bloodstream.\n*   **Drug-likeness Scores:** Assigning a score to a molecule indicating its likelihood of being a successful drug.\n\nThese companies are all working to make drug discovery more predictive, efficient, and ultimately, more successful by leveraging the power of AI to understand how potential drugs will behave in the complex biological environment.\n","output_type":"stream"}],"execution_count":19},{"cell_type":"code","source":"# Get the final session state\nfinal_session = await session_service.get_session(\n    app_name=research_runner_compacting.app_name,\n    user_id=USER_ID,\n    session_id=\"compaction_demo\",\n)\n\nprint(\"--- Searching for Compaction Summary Event ---\")\nfound_summary = False\nfor event in final_session.events:\n    # Compaction events have a 'compaction' attribute\n    if event.actions and event.actions.compaction:\n        print(\"\\nâœ… SUCCESS! Found the Compaction Event:\")\n        print(f\"  Author: {event.author}\")\n        print(f\"\\n Compacted information: {event}\")\n        found_summary = True\n        break\n\nif not found_summary:\n    print(\n        \"\\nâŒ No compaction event found. Try increasing the number of turns in the demo.\"\n    )","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T04:45:26.195923Z","iopub.execute_input":"2025-11-12T04:45:26.196308Z","iopub.status.idle":"2025-11-12T04:45:26.208868Z","shell.execute_reply.started":"2025-11-12T04:45:26.196282Z","shell.execute_reply":"2025-11-12T04:45:26.207870Z"}},"outputs":[{"name":"stdout","text":"--- Searching for Compaction Summary Event ---\n\nâœ… SUCCESS! Found the Compaction Event:\n  Author: user\n\n Compacted information: model_version=None content=None grounding_metadata=None partial=None turn_complete=None finish_reason=None error_code=None error_message=None interrupted=None custom_metadata=None usage_metadata=None live_session_resumption_update=None input_transcription=None output_transcription=None avg_logprobs=None logprobs_result=None cache_metadata=None citation_metadata=None invocation_id='62df5588-2909-4b9b-a1a5-124a7785f57f' author='user' actions=EventActions(skip_summarization=None, state_delta={}, artifact_delta={}, transfer_to_agent=None, escalate=None, requested_auth_configs={}, requested_tool_confirmations={}, compaction={'start_timestamp': 1762922665.8081, 'end_timestamp': 1762922673.712175, 'compacted_content': {'parts': [{'function_call': None, 'code_execution_result': None, 'executable_code': None, 'file_data': None, 'function_response': None, 'inline_data': None, 'text': \"The user inquired about the latest news in AI in healthcare, and the AI agent provided a comprehensive overview. Key areas discussed included drug discovery, diagnostics, predictive analytics, workflow automation, and robotic surgery. The agent also highlighted important trends and considerations such as Explainable AI (XAI), data privacy, regulatory landscapes, ethical implications, and interoperability.\\n\\nFollowing up on drug discovery, the user specifically asked about new developments. The AI agent detailed advancements in **Generative AI for Novel Molecule Design**, **AI for Predicting Drug Properties and Efficacy**, **AI in Target Identification and Validation**, **AI for Optimizing Clinical Trials**, and **AI in Repurposing Existing Drugs**.\\n\\nThe user then requested more information on the **second development** mentioned, which was **AI for Predicting Drug Properties and Efficacy**. The AI agent elaborated on this by explaining how AI significantly improves the prediction of ADMET properties (Absorption, Distribution, Metabolism, Excretion, and Toxicity), enhances Quantitative Structure-Activity Relationship (QSAR) models for better efficacy prediction, and makes virtual screening more efficient and accurate. The agent emphasized that this development is crucial for de-risking drug candidates early in the discovery process, saving time and resources.\\n\\n**Unresolved Questions/Tasks:**\\nNone. The conversation has been a series of information provision and clarification, with the user's questions being directly addressed.\", 'thought': None, 'thought_signature': None, 'video_metadata': None}], 'role': 'model'}}, end_of_agent=None, agent_state=None, rewind_before_invocation_id=None) long_running_tool_ids=set() branch=None id='d94818c6-6e20-470d-88f5-6fd4d7d219a1' timestamp=1762922678.956606\n","output_type":"stream"}],"execution_count":20},{"cell_type":"code","source":"# Define scope levels for state keys (following best practices)\nUSER_NAME_SCOPE_LEVELS = (\"temp\", \"user\", \"app\")\n\n\n# This demonstrates how tools can write to session state using tool_context.\n# The 'user:' prefix indicates this is user-specific data.\ndef save_userinfo(\n    tool_context: ToolContext, user_name: str, country: str\n) -> Dict[str, Any]:\n    \"\"\"\n    Tool to record and save user name and country in session state.\n\n    Args:\n        user_name: The username to store in session state\n        country: The name of the user's country\n    \"\"\"\n    # Write to session state using the 'user:' prefix for user data\n    tool_context.state[\"user:name\"] = user_name\n    tool_context.state[\"user:country\"] = country\n\n    return {\"status\": \"success\"}\n\n\n# This demonstrates how tools can read from session state.\ndef retrieve_userinfo(tool_context: ToolContext) -> Dict[str, Any]:\n    \"\"\"\n    Tool to retrieve user name and country from session state.\n    \"\"\"\n    # Read from session state\n    user_name = tool_context.state.get(\"user:name\", \"Username not found\")\n    country = tool_context.state.get(\"user:country\", \"Country not found\")\n\n    return {\"status\": \"success\", \"user_name\": user_name, \"country\": country}\n\n\nprint(\"âœ… Tools created.\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T04:58:44.460079Z","iopub.execute_input":"2025-11-12T04:58:44.462733Z","iopub.status.idle":"2025-11-12T04:58:44.480759Z","shell.execute_reply.started":"2025-11-12T04:58:44.462659Z","shell.execute_reply":"2025-11-12T04:58:44.479626Z"}},"outputs":[{"name":"stdout","text":"âœ… Tools created.\n","output_type":"stream"}],"execution_count":21},{"cell_type":"code","source":"# Configuration\nAPP_NAME = \"default\"\nUSER_ID = \"default\"\nMODEL_NAME = \"gemini-2.5-flash-lite\"\n\n# Create an agent with session state tools\nroot_agent = LlmAgent(\n    model=Gemini(model=\"gemini-2.5-flash-lite\", retry_options=retry_config),\n    name=\"text_chat_bot\",\n    description=\"\"\"A text chatbot.\n    Tools for managing user context:\n    * To record username and country when provided use `save_userinfo` tool. \n    * To fetch username and country when required use `retrieve_userinfo` tool.\n    \"\"\",\n    tools=[save_userinfo, retrieve_userinfo],  # Provide the tools to the agent\n)\n\n# Set up session service and runner\nsession_service = InMemorySessionService()\nrunner = Runner(agent=root_agent, session_service=session_service, app_name=\"default\")\n\nprint(\"âœ… Agent with session state tools initialized!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T05:00:48.337991Z","iopub.execute_input":"2025-11-12T05:00:48.338424Z","iopub.status.idle":"2025-11-12T05:00:48.354986Z","shell.execute_reply.started":"2025-11-12T05:00:48.338389Z","shell.execute_reply":"2025-11-12T05:00:48.353805Z"}},"outputs":[{"name":"stdout","text":"âœ… Agent with session state tools initialized!\n","output_type":"stream"}],"execution_count":22},{"cell_type":"code","source":"# Test conversation demonstrating session state\nawait run_session(\n    runner,\n    [\n        \"Hi there, how are you doing today? What is my name?\",  # Agent shouldn't know the name yet\n        \"My name is Sam. I'm from Poland.\",  # Provide name - agent should save it\n        \"What is my name? Which country am I from?\",  # Agent should recall from session state\n    ],\n    \"state-demo-session\",\n)","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T05:01:22.934754Z","iopub.execute_input":"2025-11-12T05:01:22.935996Z","iopub.status.idle":"2025-11-12T05:01:25.860358Z","shell.execute_reply.started":"2025-11-12T05:01:22.935963Z","shell.execute_reply":"2025-11-12T05:01:25.859264Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: state-demo-session\n\nUser > Hi there, how are you doing today? What is my name?\ngemini-2.5-flash-lite >  Hello! I'm doing well, thank you for asking. I can't recall your name at the moment. Could you please tell me what it is?\n\nUser > My name is Sam. I'm from Poland.\n","output_type":"stream"},{"name":"stderr","text":"WARNING:google_genai.types:Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n","output_type":"stream"},{"name":"stdout","text":"gemini-2.5-flash-lite >  Hi Sam, it's a pleasure to meet you! I'll make sure to remember that you're from Poland.\ngemini-2.5-flash-lite >  I have saved your name as Sam and your country as Poland. How else may I help you today?\n\n\nUser > What is my name? Which country am I from?\n","output_type":"stream"},{"name":"stderr","text":"WARNING:google_genai.types:Warning: there are non-text parts in the response: ['function_call'], returning concatenated text result from text parts. Check the full candidates.content.parts accessor to get the full model response.\n","output_type":"stream"},{"name":"stdout","text":"gemini-2.5-flash-lite >  Your name is Sam and you are from Poland.\n","output_type":"stream"}],"execution_count":23},{"cell_type":"code","source":"# Retrieve the session and inspect its state\nsession = await session_service.get_session(\n    app_name=APP_NAME, user_id=USER_ID, session_id=\"state-demo-session\"\n)\n\nprint(\"Session State Contents:\")\nprint(session.state)\nprint(\"\\nðŸ” Notice the 'user:name' and 'user:country' keys storing our data!\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T05:02:16.963535Z","iopub.execute_input":"2025-11-12T05:02:16.965206Z","iopub.status.idle":"2025-11-12T05:02:16.972605Z","shell.execute_reply.started":"2025-11-12T05:02:16.964930Z","shell.execute_reply":"2025-11-12T05:02:16.971417Z"}},"outputs":[{"name":"stdout","text":"Session State Contents:\n{'user:name': 'Sam', 'user:country': 'Poland'}\n\nðŸ” Notice the 'user:name' and 'user:country' keys storing our data!\n","output_type":"stream"}],"execution_count":24},{"cell_type":"code","source":"# Start a completely new session - the agent won't know our name\nawait run_session(\n    runner,\n    [\"Hi there, how are you doing today? What is my name?\"],\n    \"new-isolated-session\",\n)\n\n# Expected: The agent won't know the name because this is a different session","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T05:02:49.982897Z","iopub.execute_input":"2025-11-12T05:02:49.983700Z","iopub.status.idle":"2025-11-12T05:02:50.746053Z","shell.execute_reply.started":"2025-11-12T05:02:49.983669Z","shell.execute_reply":"2025-11-12T05:02:50.745176Z"}},"outputs":[{"name":"stdout","text":"\n ### Session: new-isolated-session\n\nUser > Hi there, how are you doing today? What is my name?\ngemini-2.5-flash-lite >  Hello! I'm doing great, thank you for asking. I can't remember your name, as I don't have access to that information. Is there anything I can help you with? \n\n","output_type":"stream"}],"execution_count":25},{"cell_type":"code","source":"# Check the state of the new session\nsession = await session_service.get_session(\n    app_name=APP_NAME, user_id=USER_ID, session_id=\"new-isolated-session\"\n)\n\nprint(\"New Session State:\")\nprint(session.state)\n\n# Note: Depending on implementation, you might see shared state here.\n# This is where the distinction between session-specific and user-specific state becomes important.","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T05:03:25.782774Z","iopub.execute_input":"2025-11-12T05:03:25.783146Z","iopub.status.idle":"2025-11-12T05:03:25.789799Z","shell.execute_reply.started":"2025-11-12T05:03:25.783119Z","shell.execute_reply":"2025-11-12T05:03:25.788529Z"}},"outputs":[{"name":"stdout","text":"New Session State:\n{'user:name': 'Sam', 'user:country': 'Poland'}\n","output_type":"stream"}],"execution_count":26},{"cell_type":"code","source":"# Clean up any existing database to start fresh (if Notebook is restarted)\nimport os\n\nif os.path.exists(\"my_agent_data.db\"):\n    os.remove(\"my_agent_data.db\")\nprint(\"âœ… Cleaned up old database files\")","metadata":{"trusted":true,"execution":{"iopub.status.busy":"2025-11-12T05:04:16.273817Z","iopub.execute_input":"2025-11-12T05:04:16.275304Z","iopub.status.idle":"2025-11-12T05:04:16.281636Z","shell.execute_reply.started":"2025-11-12T05:04:16.275261Z","shell.execute_reply":"2025-11-12T05:04:16.280427Z"}},"outputs":[{"name":"stdout","text":"âœ… Cleaned up old database files\n","output_type":"stream"}],"execution_count":27}]}